The Journal of experimental medicine · 2021
Single-cell analysis of human skin identifies CD14+ type 3 dendritic cells co-producing IL1B and IL23A in psoriasis.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nakamizo Satoshi, Dutertre Charles-Antoine, Khalilnezhad Ahad, Zhang Xiao Meng, Lim Shawn, Lum Josephine, Koh Geraldine, Foong Charlene, Yong Pearly Jean Ai, Tan Kahbing Jasmine, Sato Reiko, Tomari Kaori, Yvan-Charvet Laurent, He Helen, Guttman-Yassky Emma, Malleret Benoit, Shibuya Rintaro, Iwata Masashi, Janela Baptiste, Goto Tsuyoshi, Lucinda Tan Siyun, Tang Mark B Y, Theng Colin, Julia Valerie, Hacini-Rachinel Feriel, Kabashima Kenji, Ginhoux Florent
Аннотация
Inflammatory skin diseases including atopic dermatitis (AD) and psoriasis (PSO) are underpinned by dendritic cell (DC)-mediated T cell responses. Currently, the heterogeneous human cutaneous DC population is incompletely characterized, and its contribution to these diseases remains unclear. Here, we performed index-sorted single-cell flow cytometry and RNA sequencing of lesional and nonlesional AD and PSO skin to identify macrophages and all DC subsets, including the newly described mature LAMP3+BIRC3+ DCs enriched in immunoregulatory molecules (mregDC) and CD14+ DC3. By integrating our indexed data with published skin datasets, we generated a myeloid cell universe of DC and macrophage subsets in healthy and diseased skin. Importantly, we found that CD14+ DC3s increased in PSO lesional skin and co-produced IL1B and IL23A, which are pathological in PSO. Our study comprehensively describes the molecular characteristics of macrophages and DC subsets in AD and PSO at single-cell resolution, and identifies CD14+ DC3s as potential promoters of inflammation in PSO.